Gallic acid loaded onto polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA-GA NPs) stabilizes α-synuclein in the unfolded conformation and inhibits aggregation
Authors:
- Hossein Mohammad-BeigiHMHossein Mohammad-Beigi
- Dina MorshediDMDina Morshedi
- Seyed Abbas ShojaosadatiSSSeyed Abbas Shojaosadati
- Jannik Nedergaard PedersenJPJannik Nedergaard Pedersen
- Amir Tayaranian MarvianAMAmir Tayaranian Marvian
- Farhang AliakbariFAFarhang Aliakbari
- Gunna ChristiansenGCGunna Christiansen
- Jan Skov PedersenJan Skov Pedersen
- Daniel E. OtzenDODaniel E. Otzen
- 2 September 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (88) , 85312-85323
Abstract
The aggregation of the 140-residue protein α-synuclein (αSN) plays a major role in the pathogenesis of different neurodegenerative disorders such as Parkinson's Disease (PD).Keywords
This publication has 48 references indexed in Scilit:
- High Stability and Cooperative Unfolding of α-Synuclein OligomersBiochemistry, 2014
- Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicityFrontiers in Aging Neuroscience, 2014
- α-Synuclein Oligomers: an Amyloid Pore?Molecular Neurobiology, 2012
- Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillationProceedings of the National Academy of Sciences, 2011
- Genes and parkinsonismThe Lancet Neurology, 2003
- Amyloid pores from pathogenic mutationsNature, 2002
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's DiseaseBiochemistry, 2001
- α-Synuclein in Lewy bodiesNature, 1997
- Identification of two distinct synucleins from human brainFEBS Letters, 1994